Interleukin-2 gene therapy (Valentis)

N/A

Report date: 2022/03/09 15:35:17

Base Information

Drug NameInterleukin-2 gene therapy (Valentis)
Drug Alias NameIL-2 genemedicineInterleukin-2 genemedicineVLTS-587
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionIL2 gene transference
TargetsInterleukin-2
Therapy Area/IndicationsLung NeoplasmsHead and Neck NeoplasmsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesValentis
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesValentis
Active IndicationsN/A
Inactive IndicationsLung NeoplasmsHead and Neck NeoplasmsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A